BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.31% |
| 2 | Financials | 6.96% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.97% |
| 5 | Industrials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LAND
3651
Gladstone Land Corp
LAND
$364M
| $28.5K | ﹤0.01% |
2,399
+25
| +1% | +$291 |
|
3652
Fidelity D&D Bancorp
FDBC
$319M
| $28.5K | ﹤0.01% |
458
+43
| +10% | +$2.68K |
|
3653
Apyx Medical
APYX
$128M
| $28.5K | ﹤0.01% |
4,207
+2,798
| +199% | +$19.9K |
|
|
BOCH
3654
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $28.5K | ﹤0.01% |
2,615
+49
| +2% | +$513 |
|
3655
Target Hospitality
TH
$1.61B
| $28.4K | ﹤0.01% |
4,171
+4,086
| +4,807% | +$30.9K |
|
3656
KVH Industries
KVHI
$146M
| $28.4K | ﹤0.01% |
2,667
+112
| +4% | +$1.11K |
|
3657
PUT
Fox Class A
FOXA
$27B
| $28.4K | ﹤0.01% |
9
| – | – |
|
3658
LCNB Corp
LCNB
$281M
| $28.4K | ﹤0.01% |
1,599
-55
| -3% | -$964 |
|
3659
ADMA Biologics
ADMA
$2.16B
| $28.3K | ﹤0.01% |
6,370
+3,981
| +167% | +$16.6K |
|
|
CSTR
3660
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $28.3K | ﹤0.01% |
1,709
+73
| +4% | +$1.14K |
|
3661
Unity Bancorp
UNTY
$621M
| $28.3K | ﹤0.01% |
1,279
+53
| +4% | +$1.1K |
|
|
PVLA
3662
Palvella Therapeutics
PVLA
$2.28B
| $28.3K | ﹤0.01% |
104
+25
| +32% | +$9.68K |
|
3663
Palomar
PLMR
$3.41B
| $28.2K | ﹤0.01% |
716
+701
| +4,673% | +$21.9K |
|
3664
FVCBankcorp
FVCB
$340M
| $28.2K | ﹤0.01% |
2,008
+1,010
| +101% | +$14.4K |
|
3665
IES Holdings
IESC
$15B
| $28.1K | ﹤0.01% |
1,367
+192
| +16% | +$3.65K |
|
|
STR
3666
DELISTED
Sitio Royalties
STR
| $28K | ﹤0.01% |
1,219
+826
| +210% | +$23K |
|
3667
Bankwell Financial Group
BWFG
$540M
| $28K | ﹤0.01% |
1,019
+17
| +2% | +$463 |
|
3668
Uranium Energy
UEC
$5.62B
| $28K | ﹤0.01% |
28,733
+8,111
| +39% | +$8.22K |
|
3669
Oil-Dri
ODC
$1.27B
| $27.9K | ﹤0.01% |
1,640
+32
| +2% | +$529 |
|
3670
SoundThinking
SSTI
$109M
| $27.9K | ﹤0.01% |
1,211
+353
| +41% | +$11.4K |
|
|
STRS
3671
DELISTED
STRATUS PPTYS INC
STRS
| $27.8K | ﹤0.01% |
945
+2
| +0.2% | +$55 |
|
|
ZAGG
3672
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $27.7K | ﹤0.01% |
4,413
+6
| +0.1% | +$39 |
|
|
AAIC
3673
DELISTED
Arlington Asset Investment Corp.
AAIC
| $27.7K | ﹤0.01% |
5,039
-151
| -3% | -$889 |
|
3674
Pulse Biosciences
PLSE
$3.26B
| $27.6K | ﹤0.01% |
1,790
+544
| +44% | +$7.07K |
|
|
SBBX
3675
DELISTED
SB One Bancorp Common Stock
SBBX
| $27.6K | ﹤0.01% |
1,223
+9
| +0.7% | +$204 |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.